The Annual Report of Trends in Behaviour 2017 will be released today by the Centre for Social Research in Health (CSRH) at UNSW Sydney, alongside The Kirby Institute’s Australia Annual Surveillance Report (ASR) in HIV, viral hepatitis and sexually transmissible infections at the Australasian HIV/AIDS Conference in Canberra.
The ACT PrEP trial has commenced, and the ACT Government is providing more than $110,000 to support the local trial, which will include up to 315 participants over 15 months. The trial is being conducted through the Canberra Sexual Health Centre at Canberra Hospital and the Interchange General Practice in Civic.
The local trial is part of the Expanded Pre-Exposure Prophylaxis Implementation in Communities in NSW Trial (EPIC-NSW trial) funded by NSW Health and run by the Kirby Institute at the University of New South Wales.
The AIDS Action Council is partnering with Green Cross Pharmacy Australia to improve access to PrEP for our communities. Through our relationship with Green Cross Pharmacy, the AIDS Action Council is able to assist you in accessing PrEP for free. Find out more about this program by clicking the link below.
Transgender women living with HIV may be hesitant to use antiretroviral therapy (ART) or not take it as prescribed because of concerns about drug interactions with feminising hormones, according to a presentation at the 9th International AIDS Society Conference on HIV Science (IAS 2017) last month in Paris.
"We don’t want to look back in 30 years and realise we missed the opportunity to make history by eliminating new HIV transmissions."
Even though there has been a major drop in new HIV cases in major Australian states, new research suggests there is a long way to go to end HIV.Australia has committed to ending new HIV transmissions by 2020, but the Critical Steps Towards Addressing HIV research found it has a lot of work to do to achieve that goal.